ST. LOUIS, Nov. 8, 2011 /PRNewswire/ -- Sigma-Aldrich® (NASDAQ: SIAL) -- At the Board of Directors meeting held today, the Directors declared a quarterly cash dividend of $.18 per share. The dividend is payable on December 15, 2011 to shareholders of record on December 1, 2011. The Board of Directors ... read more

ST. LOUIS, Nov. 4, 2011 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) will be presenting at the following investor conferences in November: -- CLSA AsiaUSA Forum 2011 on Wednesday, November 9, at the Palace Hotel, San Francisco, CA, presenting at ... read more

ST. LOUIS, Oct. 27, 2011 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that its custom manufacturing and services business unit, SAFC® (www.safcglobal.com), is introducing a novel CHOZN® GS-/- Zinc Finger Nuclease (ZFN)-modified Chinese Hamster Ovary (CHO) cell line. Designed for use in the production of biopharmaceuticals, the new CHOZN ... read more

ST. LOUIS, Oct 26, 2011 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that its custom manufacturing and services business unit, SAFC® (www.safcglobal.com), has completed an assessment by SafeBridge® Consultants, Inc. and has been granted SafeBridge Certification for its commercial scale High-Potency Active Pharmaceutical Ingredients (HPAPI) facility in Verona, Wisconsin. ... read more

ST. LOUIS, Oct. 25, 2011 /PRNewswire/ -- HIGHLIGHTS: 2011 Results (all percentages are to comparable periods in 2010) -- Q3 2011 reported sales increased 11% to $626 million. Q3 sales grew organically by 4% with Research products and Fine Chemicals ("SAFC") ... read more